Bladder Cancer,Genitourinary Cancer uMRD Predicts NIMBC Recurrence & Nadofaragene Response Apr 01, 2024
Bladder Cancer,Genitourinary Cancer Neoadjuvant Nivolumab + Ipilimumab in UTUC: Updated Results Mar 28, 2024
Bladder Cancer,Genitourinary Cancer Gemcitabine/Cisplatin ± Berzosertib in mUC: Extended Follow-up Mar 26, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cabozantinib Role in Advanced Kidney Cancer: OCTOPUS Mar 14, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Plasma EV Biomarkers for CABO+DURVA Response in Advanced Mar 12, 2024
